# Phase 9: Manuscript Evidence Audit & Adversarial Peer Review

**Consolidated Steps**: Step 14 (Manuscript Evidence Audit), Step 15 (Adversarial Peer Review Challenge)  
**Primary Deliverables**: `reports/15_independent_reviewer_report.md`, `reports/15_revised_manuscript.md`, `reports/15_submission_readiness_decision.md`  

---

## 1. Scientific Objective
Execute an independent, adversarial peer review challenging central claims, verifying reference support, testing manuscript completeness, logging required revisions, and revising the research draft.

## 2. Adversarial Claim Verification
Seven claims evaluated in `reports/15_independent_claim_verification.csv`:
- Binary classification task (PRE vs POST) confirmed; fine-grained 4-class discovery refuted.
- Majority baseline superiority verified ($p_{\text{adj}} = 0.000769$).
- Physicochemical superiority classified as borderline / unproven at $\alpha=0.05$ ($p_{\text{adj}} = 0.0602$).
- Low-rank PCA generalization collapse documented as an essential finding.
- Sister-species transfer reclassified strictly as an ortholog sequence transfer diagnostic.
- External clinical isolate validation disclosed as absent.

## 3. Bibliographic Verification
All 7 cited primary references (Honess & Roizman 1974, 1975; Rutkowski et al. 2015; Kulej et al. 2017; Dremel & DeLuca 2019; Roizman et al. 2013; Lin et al. 2023) verified with valid DOIs, PMIDs, and accessible primary assays.

## 4. Readiness Decision
- Outcome: **1. READY FOR CO-AUTHOR REVIEW**.
- Explicitly separated from journal submission readiness pending publication figure compilation and supplementary packaging.

## 5. Validation & Test Outcomes
- Validated under `tests/test_14_manuscript_evidence_audit.py` and `test_15_independent_reviewer_audit.py` (18 passing tests).
